Update on Exhaled Nitric Oxide in Clinical Practice

被引：22
作者：
Mummadi, Srinivas R. [1 ]
Hahn, Peter Y. [1 ]
机构：
[1] Tual Healthcare, Dept Pulm Crit Care & Sleep Med, Hillsboro, OR 97123 USA
来源：
CHEST | 2016年 / 149卷 / 05期
关键词：
asthma; nitric oxide; RANDOMIZED CONTROLLED-TRIAL; ASTHMA; ADULTS; MANAGEMENT;
D O I：
10.1016/j.chest.2015.11.020
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
Asthma is characterized by chronic airway inflammation. Fractional exhaled nitric oxide (FENO) has emerged as a marker of T-helper cell type 2-mediated allergic airway inflammation. Recent studies suggest a role for FENO testing as a point-of-care tool in the management of patients with asthma. This Topics in Practice Management article reviews current coverage and reimbursement issues related to FENO testing and provides an overview of pertinent recent studies.
引用
收藏
页码：1340 / 1344
页数：5
相关论文
共 24 条
  • [1] Alving K, 2010, EUR RESPIR MONOGR, P1, DOI 10.1183/1025448x.00028509
  • [2] ALVING K, 1993, EUR RESPIR J, V6, P1368
  • [3] [Anonymous], 2014, THORAX, V69, P1
  • [4] Comparison of Physician-, Biomarker-, and Symptom-Based Strategies for Adjustment of Inhaled Corticosteroid Therapy in Adults With Asthma The BASALT Randomized Controlled Trial
    Calhoun, William J.
    Ameredes, Bill T.
    King, Tonya S.
    Icitovic, Nikolina
    Bleecker, Eugene R.
    Castro, Mario
    Cherniack, Reuben M.
    Chinchilli, Vernon M.
    Craig, Timothy
    Denlinger, Loren
    DiMango, Emily A.
    Engle, Linda L.
    Fahy, John V.
    Grant, J. Andrew
    Israel, Elliot
    Jarjour, Nizar
    Kazani, Shamsah D.
    Kraft, Monica
    Kunselman, Susan J.
    Lazarus, Stephen C.
    Lemanske, Robert F., Jr.
    Lugogo, Njira
    Martin, Richard J.
    Meyers, Deborah A.
    Moore, Wendy C.
    Pascual, Rodolfo
    Peters, Stephen P.
    Ramsdell, Joe
    Sorkness, Christine A.
    Sutherland, E. Rand
    Szefler, Stanley J.
    Wasserman, Stephen I.
    Walter, Michael J.
    Wechsler, Michael E.
    Boushey, Homer A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (10): : 987 - 997
  • [5] Lebrikizumab Treatment in Adults with Asthma
    Corren, Jonathan
    Lemanske, Robert F., Jr.
    Hanania, Nicola A.
    Korenblat, Phillip E.
    Parsey, Merdad V.
    Arron, Joseph R.
    Harris, Jeffrey M.
    Scheerens, Heleen
    Wu, Lawren C.
    Su, Zheng
    Mosesova, Sofia
    Eisner, Mark D.
    Bohen, Sean P.
    Matthews, John G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (12) : 1088 - 1098
  • [6] Delgado-Corcoran Claudia, 2004, Pediatr Crit Care Med, V5, P48, DOI 10.1097/01.CCM.0000105310.00799.51
  • [7] Exhaled nitric oxide to predict corticosteroid responsiveness and reduce asthma exacerbation rates
    Donohue, James F.
    Jain, Neal
    [J]. RESPIRATORY MEDICINE, 2013, 107 (07) : 943 - 952
  • [8] Emerging Roles of T Helper Subsets in the Pathogenesis of Asthma
    Durrant, Douglas M.
    Metzger, Dennis W.
    [J]. IMMUNOLOGICAL INVESTIGATIONS, 2010, 39 (4-5) : 526 - 549
  • [9] An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications
    Dweik, Raed A.
    Boggs, Peter B.
    Erzurum, Serpil C.
    Irvin, Charles G.
    Leigh, Margaret W.
    Lundberg, Jon O.
    Olin, Anna-Carin
    Plummer, Alan L.
    Taylor, D. Robin
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (05) : 602 - 615
  • [10] Use of Exhaled Nitric Oxide Measurement to Identify a Reactive, at-Risk Phenotype among Patients with Asthma
    Dweik, Raed A.
    Sorkness, Ronald L.
    Wenzel, Sally
    Hammel, Jeffrey
    Curran-Everett, Douglas
    Comhair, Suzy A. A.
    Bleecker, Eugene
    Busse, William
    Calhoun, William J.
    Castro, Mario
    Chung, Kian Fan
    Israel, Elliot
    Jarjour, Nizar
    Moore, Wendy
    Peters, Stephen
    Teague, Gerald
    Gaston, Benjamin
    Erzurum, Serpil C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181 (10) : 1033 - 1041
123